Sanofi et Alnylam mettent fin à leur collaboration | Les Echos
Sanofi, Regeneron uncouple on long-standing drug partnership, splitting up Praluent, Kevzara | Fierce Pharma
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO - Pharma Advancement
Emmanuel Barbarin - Head of Sanofi-Regeneron alliance controlling for Sanofi Industrial Affairs - Sanofi | LinkedIn
Alnylam swaps Sanofi for Regeneron as R&D partner - PMLiVE
Sanofi pays Regeneron $462M to exit immuno-oncology R&D pact | Fierce Biotech
Sanofi pourrait récolter plus de 13 Md$ en cédant des actions Regeneron | Capital Finance
Sanofi, Regeneron Restructure Immuno-Onco Alliance | Contract Pharma
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | SaltWire
Sanofi revises immuno-oncology deal with Regeneron
Industry Participation | ESMO
En Direct des Marchés : TotalEnergies, Sanofi, Apple, Alphabet, Amazon, Ford, Zur Rose... - 03/02/2023 | Zonebourse
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data | Reuters
Regeneron/Sanofi get EU okay for Dupixent in “asthma of the sinuses” | pharmaphorum
A Boston, la réunion que Sanofi ne peut pas rater
Successful Partnership Between Sanofi and Regeneron - YouTube
Sponsors | Snot Force Alliance Inc
Meet Our National Sponsors: AbbVie, maker of HUMIRA & The Sanofi and Regeneron alliance.
Regeneron, Sanofi chop cholesterol drug price in Express Scripts pact
Sanofi et Regeneron révisent leur partenariat
Regeneron purchases exclusive rights to Libtayo from Sanofi for $900M
Patentstreit: Sanofi vs. Amgen: Muss Praluent sofort vom Markt?
